This Metric Says You Are Smart to Buy Amicus Therapeutics, Inc. (FOLD)

Page 2 of 2

Using the results shown by Insider Monkey’s research, average investors should always track hedge fund and insider trading sentiment, and Amicus Therapeutics, Inc. (NASDAQ:FOLD) applies perfectly to this mantra.

Discover how hedge fund piggybacking can benefit you

Recommended Reading:

Hedge Funds Are Buying Amicus Therapeutics, Inc. (FOLD)

Hedge Fund Activity

Insider Trading Activity

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Cytokinetics, Inc. (NASDAQ:CYTK) 8 0 0
ArQule, Inc. (NASDAQ:ARQL) 10 0 0
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) 7 0 0
Pain Therapeutics, Inc. (NASDAQ:PTIE) 12 0 0
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) 8 0 0
Page 2 of 2